298 related articles for article (PubMed ID: 8799682)
1. New antiherpesvirus agents. Their targets and therapeutic potential.
Alrabiah FA; Sacks SL
Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in herpesvirus therapy.
Naesens L; De Clercq E
Herpes; 2001 Mar; 8(1):12-6. PubMed ID: 11867011
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against herpesvirus infections in transplant recipients.
Ljungman P
Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
[TBL] [Abstract][Full Text] [Related]
4. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
5. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
7. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
8. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
9. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
10. Viral skin infections in the elderly: diagnosis and management.
Bansal R; Tutrone WD; Weinberg JM
Drugs Aging; 2002; 19(7):503-14. PubMed ID: 12182687
[TBL] [Abstract][Full Text] [Related]
11. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
Snoeck R; Andrei G; De Clercq E
Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
[TBL] [Abstract][Full Text] [Related]
12. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
Fillet AM
Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
[TBL] [Abstract][Full Text] [Related]
14. Antivirals for the treatment of herpesvirus infections.
De Clercq E
J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
[TBL] [Abstract][Full Text] [Related]
15. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.
De Clercq E; Naesens L; De Bolle L; Schols D; Zhang Y; Neyts J
Rev Med Virol; 2001; 11(6):381-95. PubMed ID: 11747000
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
17. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Wagstaff AJ
Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
[TBL] [Abstract][Full Text] [Related]
18. Systemic antivirals in herpesvirus infections.
Sasadeusz JJ; Sacks SL
Dermatol Clin; 1993 Jan; 11(1):171-85. PubMed ID: 8382122
[TBL] [Abstract][Full Text] [Related]
19. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
Chakrabarty A; Tyring SK; Beutner K; Rauser M
Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
[TBL] [Abstract][Full Text] [Related]
20. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
